Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ)
CNY 16.29
(-0.12%)
CNY 16.29
(-0.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 10.31 Billion | 12.53 Billion | 10.11 Billion | 8.78 Billion | 5.82 Billion | 4.81 Billion |
| Cost of Revenue | 4.43 Billion | 4.54 Billion | 3.68 Billion | 3.11 Billion | 2.1 Billion | 1.63 Billion |
| Gross Profit | 5.88 Billion | 7.99 Billion | 6.43 Billion | 5.66 Billion | 3.71 Billion | 3.18 Billion |
| Operating Expenses | 4.13 Billion | 5.02 Billion | 4.75 Billion | 4.17 Billion | 3.03 Billion | 2.49 Billion |
| Selling, General and Administrative Expenses | 3.16 Billion | 3.41 Billion | 3.59 Billion | 3.2 Billion | 2.34 Billion | 1.9 Billion |
| Research and Development Expenses | 855.97 Million | 1.03 Billion | 792.16 Million | 654.38 Million | 390.74 Million | 316.7 Million |
| Other Expenses | -70.5 Million | 576.86 Million | 366.58 Million | 322.96 Million | 301.58 Million | -17.94 Million |
| Cost and Expenses | 8.53 Billion | 9.56 Billion | 8.43 Billion | 7.29 Billion | 5.14 Billion | 4.13 Billion |
| Operating Income | 1.77 Billion | 2.82 Billion | 1.56 Billion | 1.43 Billion | 710.17 Million | 718.95 Million |
| Interest Expense | 38.9 Million | 33.79 Million | 33.97 Million | 3.84 Million | 71.89 Thousand | 1 Million |
| Income Tax Expense | 339.9 Million | 423.82 Million | 212.08 Million | 207.54 Million | 104.84 Million | 108.04 Million |
| Earnings before Tax | 1.68 Billion | 2.78 Billion | 1.55 Billion | 1.42 Billion | 707.88 Million | 701 Million |
| Net Income | 1.35 Billion | 2.36 Billion | 1.34 Billion | 1.21 Billion | 606.5 Million | 599.22 Million |
| Earnings Per Share Basic | 0.81 | 1.41 | 0.80 | 0.73 | 0.36 | 0.36 |
| Earnings Per Share Diluted | 0.81 | 1.41 | 0.80 | 0.73 | 0.36 | 0.36 |
| Weighted Average Shares Outstanding | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion |
| Gross Margin | 0.57 | 0.64 | 0.64 | 0.64 | 0.64 | 0.66 |
| EBIT Margin | 0.22 | 0.27 | 0.20 | 0.20 | 0.17 | 0.20 |
| Profit Margin | 0.13 | 0.19 | 0.13 | 0.14 | 0.10 | 0.12 |
| EBITDA | 2.27 Billion | 3.28 Billion | 1.95 Billion | 1.7 Billion | 978.16 Million | 960.9 Million |
| Earnings Before Tax Margin | 0.17 | 0.23 | 0.16 | 0.16 | 0.12 | 0.15 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.74 Billion | 2.05 Billion | 2.47 Billion | 10.18 Billion | 1.71 Billion | 1.78 Billion |
| Cost of Revenue | 819.53 Million | 979.07 Million | 1.22 Billion | 4.59 Billion | 1.11 Billion | 744.68 Million |
| Gross Profit | 920.83 Million | 1.07 Billion | 1.25 Billion | 5.58 Billion | 605.44 Million | 1.03 Billion |
| Operating Expenses | 908.87 Million | 804.99 Million | 891.44 Million | 3.97 Billion | 1.01 Billion | 849.85 Million |
| Selling, General and Administrative Expenses | 728.68 Million | 599.82 Million | 709.29 Million | - | 749.64 Million | 928.11 Million |
| Research and Development Expenses | 178.62 Million | 203.6 Million | 180.59 Million | - | 250.9 Million | 191.1 Million |
| Other Expenses | -1.55 Million | -1.55 Million | -1.55 Million | 8.01 Million | -18.92 Million | -17.65 Million |
| Cost and Expenses | 1.72 Billion | 1.78 Billion | 2.11 Billion | 8.57 Billion | 2.13 Billion | 1.59 Billion |
| Operating Income | 11.96 Million | 270.15 Million | 362.8 Million | 1.6 Billion | -414.01 Million | 190.35 Million |
| Interest Expense | 8.42 Million | 10.48 Million | 9.55 Million | 38.9 Million | 13.02 Million | 10.07 Million |
| Income Tax Expense | 6.32 Million | 50.15 Million | 66.53 Million | 339.9 Million | -12.24 Million | 21.81 Million |
| Earnings before Tax | 28.78 Million | 274.86 Million | 368.45 Million | 1.68 Billion | -421.87 Million | 172.69 Million |
| Net Income | 24.31 Million | 226.52 Million | 303.92 Million | 1.35 Billion | -406.3 Million | 152.66 Million |
| Earnings Per Share Basic | 0.01 | 0.14 | 0.18 | - | -0.24 | 0.09 |
| Earnings Per Share Diluted | 0.01 | 0.14 | 0.18 | - | -0.24 | 0.09 |
| Weighted Average Shares Outstanding | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion |
| Gross Margin | 0.53 | 0.52 | 0.51 | 0.55 | 0.35 | 0.58 |
| EBIT Margin | 0.02 | 0.20 | 0.15 | - | -0.16 | 0.10 |
| Profit Margin | 0.01 | 0.11 | 0.12 | 0.13 | -0.24 | 0.09 |
| EBITDA | 37.21 Million | 419.71 Million | 370.05 Million | - | -268.45 Million | 174.32 Million |
| Earnings Before Tax Margin | 0.01 | 0.13 | 0.15 | 0.16 | -0.24 | 0.11 |
300417
RIVN
DELTA
ORIENTALTL
HPOL-B
LAMM-B